Patents by Inventor Maire JUNG

Maire JUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM
    Publication number: 20240117351
    Abstract: Oligonucleotide conjugates are provided herein that inhibit or reduce expression of target genes in the CNS. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with target gene expression in the CNS.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 11, 2024
    Inventors: Maire JUNG, Travis GRIM, Weimin WANG, Bob Dale BROWN
  • COMPOSITIONS AND METHODS FOR INHIBITING PLP1 EXPRESSION
    Publication number: 20240084309
    Abstract: Oligonucleotides are provided herein that inhibit PLP1 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with PLP1 expression.
    Type: Application
    Filed: August 4, 2021
    Publication date: March 14, 2024
    Inventors: Bob Dale BROWN, Maire JUNG, Armen CHANGELIAN, Chunyang ZHANG
  • COMPOSITIONS AND METHODS FOR INHIBITING MAPT EXPRESSION
    Publication number: 20230416742
    Abstract: Oligonucleotides are provided herein that inhibit MAPT gene expression, including oligonucleotides conjugated to a targeting ligand (e.g., lipid moiety). Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders, and/or conditions associated with MAPT gene expression.
    Type: Application
    Filed: May 12, 2023
    Publication date: December 28, 2023
    Inventors: Bob Dale BROWN, Henryk T. DUDEK, Seongmoon CHEONG, Shiyu WANG, Travis GRIM, Matthew Guese COSTALES, Maire JUNG
  • COMPOSITIONS AND METHODS FOR INHIBITING SNCA EXPRESSION
    Publication number: 20230416743
    Abstract: Oligonucleotides (e.g., RNAi oligonucleotides) are provided herein that inhibit SNCA gene expression, including oligonucleotides conjugated to a targeting ligand (e.g., GalNAC moiety or lipid moiety). Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders, and/or conditions associated with SNCA gene expression.
    Type: Application
    Filed: May 12, 2023
    Publication date: December 28, 2023
    Inventors: Bob Dale BROWN, Henryk T. DUDEK, Seongmoon CHEONG, Shiyu WANG, Travis GRIM, Matthew Guese COSTALES, Maire JUNG